Relay Therapeutics 

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$10,007
$-1
Gross Profit
-1,368
8,612
-1,376
EBITDA
-110,763
-90,800
-92,888
EBIT
-112,131
-92,195
-94,263
Net Income
-92,212
-81,387
-83,495
Net Change In Cash
0
10,007
-1
Free Cash Flow
-65,844
-52,103
-89,306
Cash
134,125
152,866
143,736
Basic Shares
132,821
130,843
122,576

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$25,546
$1,381
$3,029
$82,654
Gross Profit
-300,841
-2,749
-896
79,105
EBITDA
-374,153
-306,822
-222,182
-52,247
EBIT
-379,422
-310,952
-226,107
-55,796
Net Income
-341,973
-254,259
-496,808
-49,012
Net Change In Cash
25,546
1,381
3,029
82,654
Cost of Revenue
-128,325
-165,827
405,692
Free Cash Flow
-304,442
-238,552
-77,877
-104,420
Cash
143,736
998,917
958,073
447,646
Basic Shares
122,576
112,233
95,136
42,619

Earnings Calls

Quarter EPS
2024-09-30
-$0.63
2024-06-30
-$0.69
2024-03-31
-$0.62
2023-12-31
-$0.67